GEODE CAPITAL MANAGEMENT, LLC
Position in ZYBT — Zhengye Biotechnology Holding Ltd
CIK 1214717
BOSTON, MA
Position in ZYBT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,679
-$7,499 QoQ
Shares Held
29,068
0.0% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 8 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #64 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in ZYBT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,679 | 29,068 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $27,178 | 29,068 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,428 | 29,068 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $76,158 | 29,068 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $173,535 | 29,068 | Shares | Defined | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||